What We Do
Warning: main(/var/www/vhosts/pritzkerlaw.com/httpdocs/Library/FoodBorne-Illness-EColi.lbi): failed to open stream: No such file or directory in /var/www/vhosts/pritzkerlaw.com/httpdocs/fda-pacemaker-defibrillator-statement/index.htm on line 55
Warning: main(): Failed opening '/var/www/vhosts/pritzkerlaw.com/httpdocs/Library/FoodBorne-Illness-EColi.lbi' for inclusion (include_path='.:') in /var/www/vhosts/pritzkerlaw.com/httpdocs/fda-pacemaker-defibrillator-statement/index.htm on line 55
Welcome to Pritzker | Ruohonen
FDA Updated Information on Guidant Pacemakers and Defibrillators
Pritzker | Ruohonen, a product liability law firm, is reprinting the following FDA update as a public service. The Boston Scientific/Guidant Pacemakers and Defibrillators that are being removed from hospital inventories include the following:
- Certain models of INSIGNIA ® and NEXUS ® pacemakers
- CONTAK RENEWAL ® TR and CONTAK RENEWAL ® TR2 cardiac resynchronization pacemakers
- VENTAK PRIZM ® 2, VITALITY ® and VITALITY ® 2 implantable cardioverter defibrillators
FDA Update Statement on Boston Scientific/Guidant Pacemakers and Defibrillators
As part of the agency's continued commitment to keep the public informed of product safety issues, the Food and Drug Administration (FDA) today is providing this update on pacemakers and implantable defibrillators made by Guidant, a Boston Scientific company. FDA Supports Boston Scientific/Guidant's Recommendation for Physicians to Conduct Follow-up Exams of Patients.
(July 11, 2006) FDA met last week with Boston Scientific/Guidant to discuss the firm's recent announcement that several models of pacemakers and implantable defibrillators should be removed from hospital inventories because they have the potential to malfunction due to failure of the capacitor, which controls how the device holds its power supply. FDA fully supports the company's recommendation that physicians perform follow-up exams of patients with devices that may be susceptible to this malfunction. Problems may include intermittent or permanent loss of therapy, premature battery depletion or other malfunctions. FDA is closely monitoring the situation and met with Boston Scientific/Guidant to discuss their plans to investigation the problem, inform physicians and resolve the problem as quickly as possible.
"While information about the problem with these devices is still very preliminary, FDA is committed to keeping the public informed," said Daniel Schultz, M.D., Director, Center for Devices and Radiological Health, FDA. "We support Guidant's decision to notify physicians and hospitals early in the investigation, and we believe that retrieval of non-implanted devices is a prudent first step. Analysis of returned devices may uncover clues that will allow Guidant to make further recommendations to physicians regarding patient care. Early public notification was one of the important recommendations that emerged from last fall's meeting of the Heart Rhythm Society."
Boston Scientific/Guidant has confirmed five reports of device malfunction among some 27,200 patients worldwide in whom these devices were implanted. One malfunction occurred at the time of implantation. In four cases, the patients needed to have the device replaced. The patients lost consciousness in two of these cases. There are no reported deaths.
Boston Scientific/Guidant has identified certain lots of a supplier's low-voltage capacitor as the likely source of the problem. The affected products include certain models of the Insignia and Nexus pacemakers, Contak Renewal TR/TR2 cardiac resynchronization pacemakers, and Ventak Prizm 2, Vitality and Vitality 2 implantable cardioverter defibrillators. These devices were manufactured by the company's Cardiac Rhythm Management Group, formerly Boston Scientific/Guidant's CRM business, and implanted in patients between December 2005 and June 2006. For more information, a letter to both patients and physicians regarding this notification is available at www.guidant.com/physician_communications/ .
Boston Scientific/Guidant is actively investigating the capacitor failure to determine the cause, the rate of occurrence, and the time to failure. Over the next 60 days, the company's engineers will be testing the retrieved devices and analyzing the results. The company will communicate its findings to the FDA and physicians as soon as they are available.
In the meantime, as a cautionary step, Boston Scientific/Guidant has notified physicians to schedule appointments with patients implanted with affected devices as soon as possible. Physicians should examine the patient to identify any problems and to obtain information concerning when and under what circumstances these devices may fail.
"We encourage patients who have been contacted by their physicians because they may have one of the affected devices to follow their recommendation and make an appointment to have the device checked as soon as possible," Dr. Schultz said.
"The Heart Rhythm Society applauds this proactive, collaborative effort to inform patients and physicians about the most recent device notifications. This is a monumental step in providing optimal patient care and is based on the Society's draft recommendations released in April," said Anne B. Curtis, M.D., FHRS, Immediate Past President, Heart Rhythm Society. "We believe the most important step is for patients to contact their heart rhythm specialist to determine the best course of action."
FDA is interested in receiving information about problems with any devices and encourages hospitals and the public to submit reports directly to MedWatch, the FDA's voluntary reporting program. Reports may also be submitted by phone at 1-800-FDA-1088; by fax at 1-800-FDA-0178; by mail to MedWatch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857-9787; or online at http://www.fda.gov/medwatch/report.htm.
Source: FDA update statement (http://www.fda.gov/bbs/topics/NEWS/2006/NEW01407.html)
Free Case Consultation
Foodbourne Illness Featured Topics
New York E. coli Outbreak
The Stew Leonard’s store in Yonkers, New York, has recalled 96% lean ground round because three people from one family have confirmed E. coli O157:H7 infections associated with consuming ground beef sold at the store. Read the press release regarding the Stew Leonard's ground beef recall and E. coli lawsuit information.
Oregon and Washington E. coli Outbreak
Pritzker | Ruohonen is monitoring an E. coli outbreak linked to ground beef sold at Safeway, QFC, and Fred Meyer stores in Oregon, Washington, Alaska, and Idaho under the "Northwest Finest" brand name. There are 8 confirmed cases of E. coli O157:H7 in Oregon and Washington.
Dole Recall of Bagged Lettuce Salad
Dole Fresh Vegetables, a division of Dole Food Company, Inc., has announced a recall of "Dole Hearts Delight" salad sold in the U.S. and Canada with a "best if used by (BIUB)" date of September 19, 2007, and a production code of "A24924A" or "A24924B" stamped on the package.
Shaw's Ground Beef Recall
The FSIS has announced a recall involving about 884 pounds of ground beef that may be contaminated with E. coli O157:H7. The ground beef was sold at Shaw's grocery stores in Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.
Listeria: Jensen's Smoked Salmon Spread Recall
On September 8, 2007, Jensen's Old Fashioned Smokehouse Inc. recalled two smoked salmon spread products because they may be contaminated with Listeria monocytogenes.
Listeria: Organic Raw Cream Recall
The California Department of Food and Agriculture has announced an organic raw cream recall due to possible contamination with Listeria monocytogenes. Read more about the organic raw cream recall.
Kroger Potato Salad Recall
The Ohio Department of Agriculture (ODA) is advising consumers not to consume Kroger brand Mustard or Southern-Style potato salad with a "Best If Used By" date of Sept. 5, 2007, because it may contain E. coli O157:H7.
Metz Fresh Spinach Recalled - Salmonella Risk
Metz Fresh, LLC has recalled bagged spinach as a result of a positive test for Salmonella found during routine company testing. The recalled Metz Fresh spinach bears the tracking codes 12208114, 12208214 and 12208314. It was distributed in the continental United States and Canada.
Salmonella Outbreak Linked to Arby's
Grant County Health District and their regional epidemiologist, with cooperation from the Washington Department of Health, have linked some of the reported 17 cases of Salmonella Senftenberg in the county to the Arby’s Restaurant on Stratford Road in Moses Lake, Washington.
Souplantation Shigella Outbreak
Pritzker | Ruohonen is investigation a Shigella outbreak that, according to health officials, is associated with the Souplantation restaurant in Pasadena, California. At least 44 people may have been sickened. Additional reported cases are awaiting confirmation and are still being investigated.
Baby Carrots Recalled - Possible Shigella
Los Angeles Salad Company has recalled baby carrots that were distributed and sold in Arizona, California, Florida, Georgia, Nevada, New Mexico, Oregon, Tennessee, and Washington. The recalled baby carrots may be contaminated with Shigella.
Acme Smoked Salmon Recall
Acme Smoked Fish Corporation has recalled 132 lbs of 4 oz. Smoked Salmon (Acme NY Original) and 114 lbs of 8 oz. Smoked Salmon (Acme NY Original) due to possible contamination with Listeria monocytogenes. This product was distributed to retail stores in the South Florida Region.
Listeria Recall: Regal King Seafood Dips
The FDA has announced the recall of Regal King seafood dips due to possible contamination with Listeria monocytogenes. The seafood dips were sent to A & P warehouses in 5-pound packages, repackaged, and sold at A & P stores in clear plastic containers with a Regal King label.
Listeria in Neparovana Smoked Sausage
The New York State Department of Agriculture is warning consumers that Neparovana smoked sausage may be contaminated with Listeria monocytogenes. The potentially-contaminated Neparovana smoked sausage was sold in bulk at Muncan Food Corp, 676 Seneca Avenue, Ridgewood, Queens.
